Correlation
The correlation between AMPH and CORT is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
AMPH vs. CORT
Compare and contrast key facts about Amphastar Pharmaceuticals, Inc. (AMPH) and Corcept Therapeutics Incorporated (CORT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMPH or CORT.
Performance
AMPH vs. CORT - Performance Comparison
Loading data...
Key characteristics
AMPH:
-0.99
CORT:
1.24
AMPH:
-1.38
CORT:
3.64
AMPH:
0.83
CORT:
1.50
AMPH:
-0.60
CORT:
3.19
AMPH:
-1.26
CORT:
8.12
AMPH:
30.84%
CORT:
17.89%
AMPH:
39.69%
CORT:
121.27%
AMPH:
-64.63%
CORT:
-94.28%
AMPH:
-60.45%
CORT:
-32.10%
Fundamentals
AMPH:
$1.21B
CORT:
$8.24B
AMPH:
$2.76
CORT:
$1.15
AMPH:
9.32
CORT:
67.44
AMPH:
2.77
CORT:
0.61
AMPH:
1.66
CORT:
12.03
AMPH:
1.61
CORT:
12.02
AMPH:
$728.26M
CORT:
$685.45M
AMPH:
$365.89M
CORT:
$674.70M
AMPH:
$255.58M
CORT:
$111.33M
Returns By Period
In the year-to-date period, AMPH achieves a -30.76% return, which is significantly lower than CORT's 53.92% return. Over the past 10 years, AMPH has underperformed CORT with an annualized return of 5.00%, while CORT has yielded a comparatively higher 28.58% annualized return.
AMPH
-30.76%
7.66%
-43.11%
-39.26%
-11.54%
6.64%
5.00%
CORT
53.92%
8.51%
34.47%
157.08%
54.97%
38.64%
28.58%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMPH vs. CORT — Risk-Adjusted Performance Rank
AMPH
CORT
AMPH vs. CORT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
AMPH vs. CORT - Dividend Comparison
Neither AMPH nor CORT has paid dividends to shareholders.
Drawdowns
AMPH vs. CORT - Drawdown Comparison
The maximum AMPH drawdown since its inception was -64.63%, smaller than the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for AMPH and CORT.
Loading data...
Volatility
AMPH vs. CORT - Volatility Comparison
Amphastar Pharmaceuticals, Inc. (AMPH) has a higher volatility of 11.45% compared to Corcept Therapeutics Incorporated (CORT) at 9.13%. This indicates that AMPH's price experiences larger fluctuations and is considered to be riskier than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
AMPH vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMPH vs. CORT - Profitability Comparison
AMPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Amphastar Pharmaceuticals, Inc. reported a gross profit of 85.25M and revenue of 170.53M. Therefore, the gross margin over that period was 50.0%.
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Corcept Therapeutics Incorporated reported a gross profit of 154.81M and revenue of 157.21M. Therefore, the gross margin over that period was 98.5%.
AMPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Amphastar Pharmaceuticals, Inc. reported an operating income of 37.29M and revenue of 170.53M, resulting in an operating margin of 21.9%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Corcept Therapeutics Incorporated reported an operating income of 3.42M and revenue of 157.21M, resulting in an operating margin of 2.2%.
AMPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Amphastar Pharmaceuticals, Inc. reported a net income of 25.29M and revenue of 170.53M, resulting in a net margin of 14.8%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Corcept Therapeutics Incorporated reported a net income of 20.29M and revenue of 157.21M, resulting in a net margin of 12.9%.